Signaling pathways and late‐onset gene induction associated with renal mesangial cell hypertrophy

In chronic diseases such as diabetes mellitus, continuous stress stimuli trigger a persistent, self‐reinforcing reprogramming of cellular function and gene expression that culminates in the pathological state. Late‐onset, stable changes in gene expression hold the key to understanding the molecular basis of chronic diseases. Renal failure is a common, but poorly understood complication of diabetes. Diabetic nephropathy begins with mesangial cell hypertrophy and hyperplasia, combined with excess matrix deposition. The vasoactive peptide endothelin promotes the mesangial cell hypertophy characteristic of diabetic nephropathy. In this study, we examined the signaling pathways and changes in gene expression required for endothelin‐induced mesangial cell hypertrophy. Transcriptional profiling identified seven genes induced with slow kinetics by endothelin. Of these, p8, which encodes a small basic helix–loop–helix protein, was most strongly and stably induced. p8 is also induced in diabetic kidney. Mesangial cell hypertrophy and p8 induction both require activation of the ERK, JNK/SAPK and PI‐3‐K pathways. Small interfering RNA (siRNA)‐mediated RNA interference indicates that p8 is required for endothelin‐induced hypertrophy. Thus, p8 is a novel marker for diabetic renal hypertrophy.

[1]  J. Dagorn,et al.  The HMG-I/Y-related Protein p8 Binds to p300 and Pax2trans-Activation Domain-interacting Protein to Regulate thetrans-Activation Activity of the Pax2A and Pax2B Transcription Factors on the Glucagon Gene Promoter* , 2002, The Journal of Biological Chemistry.

[2]  M. Mussap,et al.  Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. , 2002, Kidney international.

[3]  R. Feil,et al.  p8-deficient fibroblasts grow more rapidly and are more resistant to adriamycin-induced apoptosis , 2002, Oncogene.

[4]  J. Dagorn,et al.  p8 is critical for tumour development induced by rasV12 mutated protein and E1A oncogene , 2002, EMBO reports.

[5]  E. Olson,et al.  Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Iovanna,et al.  Cloning and expression of the human p8, a nuclear protein with mitogenic activity. , 2001, European journal of biochemistry.

[7]  David W. Anderson,et al.  SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  B. Hemmings,et al.  Ten years of protein kinase B signalling: a hard Akt to follow. , 2001, Trends in biochemical sciences.

[9]  J. Woodgett,et al.  PKB/AKT: functional insights from genetic models , 2001, Nature Reviews Molecular Cell Biology.

[10]  F Vinicor,et al.  The continuing epidemics of obesity and diabetes in the United States. , 2001, JAMA.

[11]  D R Alessi,et al.  PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? , 2001, Journal of cell science.

[12]  Marc Montminy,et al.  Transcriptional regulation by the phosphorylation-dependent factor CREB , 2001, Nature Reviews Molecular Cell Biology.

[13]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[14]  J. Iovanna,et al.  Overexpression of p8 is inversely correlated with apoptosis in pancreatic cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  J. Avruch,et al.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. , 2001, Physiological reviews.

[16]  R. Morimoto,et al.  Bag1–Hsp70 mediates a physiological stress signalling pathway that regulates Raf-1/ERK and cell growth , 2001, Nature Cell Biology.

[17]  J. Neal,et al.  Glycogen Synthase Kinase-3 Inhibits the DNA Binding Activity of NFATc* , 2001, The Journal of Biological Chemistry.

[18]  M. E. Ruaro,et al.  Gas6 Induces Growth, β-Catenin Stabilization, and T-Cell Factor Transcriptional Activation in Contact-Inhibited C57 Mammary Cells , 2001, Molecular and Cellular Biology.

[19]  J. Iovanna,et al.  Expression of p8 in human pancreatic cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  J. González-Ros,et al.  Human p8 Is a HMG-I/Y-like Protein with DNA Binding Activity Enhanced by Phosphorylation* , 2001, The Journal of Biological Chemistry.

[21]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[22]  T. Tuschl,et al.  RNA interference is mediated by 21- and 22-nucleotide RNAs. , 2001, Genes & development.

[23]  R. Kitsis,et al.  The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice , 2000, The EMBO journal.

[24]  John C. Lee,et al.  Extracellular Signal-regulated Kinase Plays an Essential Role in Hypertrophic Agonists, Endothelin-1 and Phenylephrine-induced Cardiomyocyte Hypertrophy* , 2000, The Journal of Biological Chemistry.

[25]  B. Burgering,et al.  Forkhead transcription factors are targets of signalling by the proto‐oncogene PKB (C‐AKT) , 2000, Journal of anatomy.

[26]  J. Molkentin Calcineurin and beyond: cardiac hypertrophic signaling. , 2000, Circulation research.

[27]  J. Woodgett,et al.  Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy , 2000, The Journal of cell biology.

[28]  P. Cohen,et al.  Specificity and mechanism of action of some commonly used protein kinase inhibitors , 2000 .

[29]  K. Mostov,et al.  Membrane traffic in polarized epithelial cells. , 2000, Current opinion in cell biology.

[30]  J. Bonventre,et al.  Gene 33/Mig-6, a Transcriptionally Inducible Adapter Protein That Binds GTP-Cdc42 and Activates SAPK/JNK* , 2000, The Journal of Biological Chemistry.

[31]  M. Bogoyevitch Signalling via stress-activated mitogen-activated protein kinases in the cardiovascular system. , 2000, Cardiovascular research.

[32]  E. Hovig,et al.  Expression of a novel factor in human breast cancer cells with metastatic potential. , 1999, Cancer research.

[33]  J. Guerrero,et al.  Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases. , 1999, The Journal of clinical investigation.

[34]  John Calvin Reed,et al.  An Evolutionarily Conserved Family of Hsp70/Hsc70 Molecular Chaperone Regulators* , 1999, The Journal of Biological Chemistry.

[35]  R. Hajjar,et al.  Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy. , 1998, The Journal of clinical investigation.

[36]  D. Alessi,et al.  Mitogen‐ and stress‐activated protein kinase‐1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB , 1998, The EMBO journal.

[37]  J. Bonventre,et al.  Mitogen‐activated protein kinases and transcriptional responses in renal injury and repair , 1998, Current opinion in nephrology and hypertension.

[38]  Jeffrey Robbins,et al.  A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.

[39]  G. Bokoch,et al.  Human myosin-IXb is a mechanochemically active motor and a GAP for rho. , 1998, Journal of cell science.

[40]  Jiahuai Han,et al.  Cardiac Hypertrophy Induced by Mitogen-activated Protein Kinase Kinase 7, a Specific Activator for c-Jun NH2-terminal Kinase in Ventricular Muscle Cells* , 1998, The Journal of Biological Chemistry.

[41]  A. Hall,et al.  Rho GTPases and the actin cytoskeleton. , 1998, Science.

[42]  J Ross,et al.  Cardiac Muscle Cell Hypertrophy and Apoptosis Induced by Distinct Members of the p38 Mitogen-activated Protein Kinase Family* , 1998, The Journal of Biological Chemistry.

[43]  J. Iovanna,et al.  Cloning and Expression of the Rat p8 cDNA, a New Gene Activated in Pancreas during the Acute Phase of Pancreatitis, Pancreatic Development, and Regeneration, and Which Promotes Cellular Growth* , 1997, The Journal of Biological Chemistry.

[44]  Colin B. Reese,et al.  3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase , 1997, Current Biology.

[45]  E. Ruaro,et al.  Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts , 1997, Molecular and cellular biology.

[46]  O. Kranenburg,et al.  Identification of a Novel, Putative Rho-specific GDP/GTP Exchange Factor and a RhoA-binding Protein: Control of Neuronal Morphology , 1997, The Journal of cell biology.

[47]  P. Cohen,et al.  Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα , 1997, Current Biology.

[48]  P. Cohen,et al.  Mechanism of activation of protein kinase B by insulin and IGF‐1. , 1996, The EMBO journal.

[49]  L Timmermann,et al.  The mechanism of action of cyclosporin A and FK506. , 1996, Clinical immunology and immunopathology.

[50]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[51]  M. Simon,et al.  Activation of phospholipase C beta 4 by heterotrimeric GTP-binding proteins. , 1994, The Journal of biological chemistry.

[52]  H. Abboud,et al.  Platelet derived growth factor-A chain gene expression in cultured mesangial cells: Regulation by phorbol ester at the level of mRNA abundance, transcription and mRNA stability , 1993, Molecular and Cellular Endocrinology.

[53]  Tony Hunter,et al.  Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity , 1991, Cell.

[54]  H. Abboud,et al.  Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogens. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Kreisberg,et al.  Vasoactive agents affect mesangial cell adhesion. , 1986, The American journal of physiology.

[56]  J. Epstein,et al.  Getting your Pax straight: Pax proteins in development and disease. , 2002, Trends in genetics : TIG.

[57]  John F. Timms,et al.  Cellular function of phosphoinositide 3-kinases: Implications for development, immunity, homeostasis, and cancer , 2001 .

[58]  K. Okkenhaug,et al.  Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. , 2001, Annual review of cell and developmental biology.

[59]  J. Woodgett Protein kinase functions , 2000 .

[60]  R. Hajjar,et al.  Signaling pathways mediating the response to hypertrophic stress in the heart. , 1999, Gene expression.

[61]  P. Hogan,et al.  Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.

[62]  B. Hosler,et al.  Copper/zinc superoxide dismutase mutations and free radical damage in amyotrophic lateral sclerosis. , 1995, Advances in neurology.